Glass House Group, one of California’s largest cannabis cultivators, is preparing to make history as its shares begin trading on the New York Stock Exchange (NYSE) on Tuesday. The move marks another milestone for the U.S. cannabis industry, making Glass House only the second American company that directly handles cannabis to secure a listing on the exchange.
The company’s successful uplisting follows a strategic restructuring that separated its medical cannabis operations from its adult-use retail business. By operating solely as a medical cannabis company, Glass House was able to meet NYSE listing requirements, a path first taken by Florida-based cannabis operator Trulieve.
Company President Graham Farrar said the transition has been in the works for nearly a year and reflects Glass House’s commitment to operating within evolving federal guidelines. The restructuring came after the U.S. Department of Justice finalized an order in April reclassifying state-licensed medical cannabis as a Schedule III controlled substance, allowing eligible companies to pursue registration with the U.S. Drug Enforcement Administration.
Investor enthusiasm has been evident in recent trading activity. Shares of Glass House climbed from $11.01 on Wednesday to approximately $12.30 by Friday, pushing the company’s market valuation to around $1 billion ahead of its NYSE debut.
As part of the corporate restructuring, Glass House transferred its California adult-use retail operations into a separate entity known as Glass House Retail. While still maintaining a majority ownership stake, the company sold a minority interest to outside investor NSJB Investments, creating a structure designed to comply with exchange regulations.
Glass House is also exploring opportunities beyond California by working with state regulators to legally export cannabis to other DEA-licensed operators. The company joins several other major U.S. cannabis firms seeking access to larger stock exchanges as federal cannabis policies continue to evolve.
Despite the positive momentum, Glass House continues to address scrutiny following immigration enforcement actions at its facilities last year. California regulators recently issued a fine related to age verification procedures for employees, though the company is appealing the penalty. State officials have previously stated they did not observe underage workers during inspections conducted before the federal raids.
The NYSE listing represents a significant step forward for Glass House and highlights the gradual shift toward greater institutional acceptance of the regulated U.S. cannabis industry.
Read the whole article here.
